Index S&P 500
P/E 29.65
EPS (ttm) 2.32
Insider Own 0.33%
Shs Outstand 352.90M
Perf Week -0.10%
Market Cap 24.22B
Forward P/E 18.82
EPS next Y 3.66
Insider Trans -3.96%
Shs Float 350.27M
Perf Month 6.08%
Income 827.80M
PEG 4.30
EPS next Q 0.94
Inst Own 97.60%
Short Float / Ratio 0.74% / 1.28
Perf Quarter -11.15%
Sales 6.01B
P/S 4.03
EPS this Y 7.68%
Inst Trans -8.32%
Short Interest 2.60M
Perf Half Y 0.75%
Book/sh 28.68
P/B 2.40
EPS next Y 7.96%
ROA 5.25%
Target Price 78.93
Perf Year 3.58%
Cash/sh 2.03
P/C 33.91
EPS next 5Y 6.90%
ROE 8.50%
52W Range 62.70 - 79.90
Perf YTD 7.25%
Dividend 0.29
P/FCF 19.20
EPS past 5Y -6.70%
ROI 6.77%
52W High -13.75%
Beta 1.14
Dividend % 0.41%
Quick Ratio 0.79
Sales past 5Y 1.73%
Gross Margin 58.87%
52W Low 9.90%
ATR 1.11
Employees 18000
Current Ratio 1.02
Sales Q/Q 2.64%
Oper. Margin 18.83%
RSI (14) 54.55
Volatility 1.65% 1.35%
Optionable Yes
Debt/Eq 0.29
EPS Q/Q 15.38%
Profit Margin 13.77%
Rel Volume 0.34
Prev Close 68.68
Shortable Yes
LT Debt/Eq 0.21
Earnings Oct 25 BMO
Payout 13.38%
Avg Volume 2.03M
Price 68.91
Recom 1.90
SMA20 2.10%
SMA50 -0.93%
SMA200 -2.07%
Volume 490,326
Change 0.33%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-26-23 Downgrade
BofA Securities
Buy → Neutral
$70
Oct-05-23 Initiated
Exane BNP Paribas
Outperform
$91
Aug-07-23 Initiated
Seaport Research Partners
Buy
$92
Mar-27-23 Upgrade
Vertical Research
Hold → Buy
$74
Oct-12-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$68 → $73
Mar-17-22 Upgrade
Argus
Hold → Buy
$68
Mar-14-22 Upgrade
Barclays
Equal Weight → Overweight
$75
Jan-03-22 Downgrade
Vertical Research
Buy → Hold
$82
Dec-17-21 Initiated
Mizuho
Neutral
$82
Nov-23-21 Initiated
Loop Capital
Buy
$90
Oct-08-21 Initiated
Wells Fargo
Equal Weight
$72
Jul-12-21 Upgrade
Wolfe Research
Peer Perform → Outperform
May-20-21 Upgrade
JP Morgan
Neutral → Overweight
$70 → $80
Feb-17-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$75
Dec-08-20 Downgrade
Wolfe Research
Outperform → Peer Perform
$71 → $78
Dec-04-20 Initiated
UBS
Buy
$83
Nov-30-20 Downgrade
Barclays
Overweight → Equal Weight
$72
Jun-25-20 Upgrade
Robert W. Baird
Neutral → Outperform
$80
Jun-05-20 Upgrade
Vertical Research
Hold → Buy
$75
May-19-20 Resumed
Morgan Stanley
Overweight
$72
Show Previous Ratings
Dec-05-23 08:00AM
Nov-24-23 11:31AM
Nov-02-23 04:15PM
Oct-31-23 04:15PM
Oct-27-23 02:29PM
11:09AM
Loading…
Oct-26-23 11:09AM
09:56AM
08:44AM
05:01AM
(Thomson Reuters StreetEvents)
Oct-25-23 10:17AM
09:48AM
07:51AM
(Associated Press Finance)
07:30AM
Oct-23-23 06:53AM
06:51AM
06:00AM
Loading…
06:00AM
Oct-19-23 09:00AM
Oct-18-23 10:01AM
Oct-03-23 02:37PM
Sep-29-23 05:30PM
Sep-19-23 10:30AM
Sep-12-23 11:00AM
Aug-31-23 12:16PM
Aug-30-23 04:15PM
12:41PM
Aug-29-23 01:02PM
Aug-24-23 05:27PM
Aug-18-23 11:39AM
Aug-17-23 05:15PM
Aug-03-23 03:52PM
07:30AM
Loading…
Jul-27-23 07:30AM
07:30AM
06:19AM
Jul-26-23 08:05PM
07:41AM
07:30AM
Jul-20-23 02:30PM
Jul-06-23 01:13PM
Jun-29-23 04:15PM
Jun-28-23 10:24AM
Jun-27-23 10:07AM
07:37AM
07:22AM
Jun-22-23 08:00AM
Jun-05-23 04:15PM
01:00PM
Jun-02-23 01:38PM
Jun-01-23 06:39AM
May-26-23 12:35PM
08:04AM
May-25-23 09:50AM
07:00AM
May-22-23 06:55AM
May-15-23 01:38PM
01:38PM
May-12-23 07:00AM
May-08-23 03:15PM
May-03-23 12:53PM
May-01-23 09:18AM
Apr-27-23 08:57AM
04:30AM
(Thomson Reuters StreetEvents)
Apr-26-23 07:43PM
01:10PM
07:30AM
Apr-06-23 04:15PM
01:00PM
11:00AM
Apr-05-23 08:55AM
Mar-29-23 04:15PM
Mar-14-23 04:23PM
Mar-10-23 04:15PM
Mar-07-23 07:04AM
Mar-03-23 11:30AM
06:02AM
Feb-24-23 02:05PM
Feb-13-23 09:50AM
07:35AM
Market Digest: CENT, CHD, EQR, SPGI, NOV, GEN, JCI, UTI, HCA, WRK, FTV, UBER, NET
(Argus Research)
07:35AM
Feb-10-23 12:31PM
Feb-09-23 07:27PM
04:15PM
04:15PM
07:05AM
Feb-02-23 03:50PM
06:27AM
Feb-01-23 05:54PM
07:30AM
Jan-27-23 11:51AM
Jan-24-23 04:15PM
Jan-19-23 07:53AM
Jan-10-23 02:09PM
(American City Business Journals)
Jan-05-23 04:15PM
Dec-22-22 05:51AM
Dec-05-22 09:00AM
Nov-24-22 03:48PM
Nov-22-22 06:36AM
Nov-16-22 08:47AM
Nov-08-22 05:45AM
Nov-03-22 04:15PM
Nov-02-22 07:56PM
Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded on November 10, 2015, and is headquartered in Everett, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LICO JAMES A President and CEO Jul 28 Option Exercise 27.26 185,540 5,057,820 485,797 Jul 31 05:47 PM Murphy Patrick K President & CEO of AHS Jul 28 Option Exercise 35.38 21,793 771,036 82,509 Jul 31 05:49 PM McLaughlin Charles E SVP - Chief Financial Officer Jul 28 Option Exercise 27.26 16,911 460,994 118,230 Jul 31 05:51 PM Mulhall Christopher M. VP - Chief Accounting Officer Jul 28 Option Exercise 29.63 4,436 131,436 10,549 Jul 31 05:54 PM Mulhall Christopher M. VP - Chief Accounting Officer Jul 28 Option Exercise 29.32 3,869 113,434 26,207 Jul 31 05:54 PM Murphy Patrick K President & CEO of AHS Jul 28 Sale 76.50 21,793 1,667,164 60,716 Jul 31 05:49 PM McLaughlin Charles E SVP - Chief Financial Officer Jul 28 Sale 76.66 16,911 1,296,397 101,319 Jul 31 05:51 PM Mulhall Christopher M. VP - Chief Accounting Officer Jul 28 Sale 76.85 4,700 361,195 21,507 Jul 31 05:54 PM Mulhall Christopher M. VP - Chief Accounting Officer Jul 28 Sale 76.84 4,436 340,862 6,113 Jul 31 05:54 PM Walker Stacey A. SVP - Human Resources Feb 27 Sale 67.75 3,249 220,120 32,721 Feb 27 06:51 PM Walker Stacey A. SVP - Human Resources Feb 23 Sale 66.39 1,336 88,697 37,946 Feb 23 08:33 PM Schwarz Jonathan L SVP - Corporate Development Feb 21 Option Exercise 24.75 14,026 347,144 57,000 Feb 22 07:40 PM Walker Stacey A. SVP - Human Resources Feb 17 Sale 68.67 2,063 141,666 40,150 Feb 21 08:34 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite